A Toronto-based team is launching a massive, years-long research project to study liquid biopsies, a novel technology meant to catch tiny traces of tumour DNA in the blood. The goal? Finding better ways to protect cancer survivors from having the disease come back, while sparing some from enduring costly, invasive treatments.